Lot Number 9RSL001ZE |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 12/01/2020 |
Event Type
Injury
|
Event Description
|
Was not able to walk, her knees became swollen, knees drained arthrocentesis.
Case narrative: initial information received on (b)(6) 2021 regarding a solicited valid serious case received from the patient, in the scope of post-marketing sponsored study "spon i synvisc one".
Patient id: (b)(6); country: (b)(6), study title: patient support program involving synvisc one.
This case involves a (b)(6)female patient who was not able to walk, her knees became swollen and her knees drained with the use of medical device hylan g-f 20, sodium hyaluronate (synvisc one).
The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.
On (b)(6) 2020, the patient started using hylan g-f 20, sodium hyaluronate injection at the dosage of 6 ml for once only via unknown route (lot - 9rsl001ze) for osteoarthritis in left knee.
On the dec-2020, after the latency of two weeks of starting the treatment with hylan g-f 20, sodium hyaluronate, her knee became swollen (joint swelling) and was not able to walk (gait inability).
Her knee was drained (aspiration joint).
Action taken: not applicable for all the events.
Corrective treatment: not reported for aspiration joint; arthrocentesis for rest both the events.
Outcome: recovered for all the events.
Reporter causality: related for all the events.
Company causality: reportable for all the events.
|
|
Event Description
|
Was not able to walk, her knees became swollen, knees drained arthrocentesis.
Case narrative: initial information received on (b)(6) 2021 regarding a solicited valid serious case received from the patient, in the scope of post-marketing sponsored study "spon i synvisc one".
Patient id: (b)(6); country: (b)(6), study title: patient support program involving synvisc one.
This case involves a (b)(6)female patient who was not able to walk, her knees became swollen and her knees drained with the use of medical device hylan g-f 20, sodium hyaluronate (synvisc one).
The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.
On (b)(6) 2020, the patient started using hylan g-f 20, sodium hyaluronate injection at the dosage of 6 ml for once only via unknown route (lot - 9rsl001ze) for osteoarthritis in left knee.
On the (b)(6) 2020, after the latency of two weeks of starting the treatment with hylan g-f 20, sodium hyaluronate, her knee became swollen (joint swelling) and was not able to walk (gait inability).
Her knee was drained (aspiration joint).
Action taken: not applicable for all the events.
Corrective treatment: not reported for aspiration joint; arthrocentesis for rest both the events.
Outcome: recovered for all the events.
Reporter causality: related for all the events.
Company causality: reportable for all the events.
|
|
Search Alerts/Recalls
|
|